200 related articles for article (PubMed ID: 37821969)
21. The metabolic syndrome increases cardiovascular mortality in Taiwanese elderly.
Wen CJ; Lee YS; Lin WY; Huang HL; Yao CA; Sung PK; Huang KC
Eur J Clin Invest; 2008 Jul; 38(7):469-75. PubMed ID: 18505405
[TBL] [Abstract][Full Text] [Related]
22. Modification of the all-cause and cardiovascular disease related mortality risk with changes in the metabolic syndrome status: a population-based prospective cohort study in Taiwan.
Lai YJ; Yen YF; Chen LJ; Hsu LF; Ahmadi MN; Inan-Eroglu E; Ku PW; Stamatakis E
Diabetes Metab; 2023 May; 49(3):101415. PubMed ID: 36563960
[TBL] [Abstract][Full Text] [Related]
23. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.
Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; March CE; Balbín E; Stavile RN; Reaven GM
J Intern Med; 2013 Jun; 273(6):595-601. PubMed ID: 23331522
[TBL] [Abstract][Full Text] [Related]
24. Metabolic Syndrome Over 4 Years Before the Onset of Cardiovascular Disease - Nested Case-Control Study.
Hu H; Nakagawa T; Honda T; Yamamoto S; Nanri A; Konishi M; Okazaki H; Kuwahara K; Hori A; Nishiura C; Kashino I; Imai T; Nishihara A; Akter S; Miyamoto T; Sasaki N; Ogasawara T; Uehara A; Yamamoto M; Murakami T; Shimizu M; Eguchi M; Kochi T; Nagahama S; Tomita K; Kabe I; Mizoue T; Sone T; Dohi S;
Circ J; 2018 Jan; 82(2):430-436. PubMed ID: 28931789
[TBL] [Abstract][Full Text] [Related]
25. Impact of blood pressure and other components of the metabolic syndrome on the development of cardiovascular disease.
Kang G; Guo L; Guo Z; Hu X; Wu M; Zhou Z; Zhou H; Liu S; Chen F
Circ J; 2010 Mar; 74(3):456-61. PubMed ID: 20057161
[TBL] [Abstract][Full Text] [Related]
26. Association of remnant cholesterol with risk of cardiovascular disease events, stroke, and mortality: A systemic review and meta-analysis.
Yang XH; Zhang BL; Cheng Y; Fu SK; Jin HM
Atherosclerosis; 2023 Apr; 371():21-31. PubMed ID: 36966562
[TBL] [Abstract][Full Text] [Related]
27. Associations of Metabolic Syndrome and its Components With Mortality in the Elderly: A Cohort Study of 73,547 Taiwanese Adults.
Yen YF; Hu HY; Lin IF; Lai YJ; Su VY; Pan SW; Ting WY; Su WJ
Medicine (Baltimore); 2015 Jun; 94(23):e956. PubMed ID: 26061328
[TBL] [Abstract][Full Text] [Related]
28. Low Carbohydrate Diets and Estimated Cardiovascular and Metabolic Syndrome Risk in Prostate Cancer.
Freedland SJ; Howard LE; Ngo A; Ramirez-Torres A; Csizmadi I; Cheng S; Mack A; Lin PH
J Urol; 2021 Dec; 206(6):1411-1419. PubMed ID: 34259565
[TBL] [Abstract][Full Text] [Related]
29. Association of remnant cholesterol with chronic kidney disease in middle-aged and elderly Chinese: a population-based study.
Yan P; Xu Y; Miao Y; Bai X; Wu Y; Tang Q; Zhang Z; Yang J; Wan Q
Acta Diabetol; 2021 Dec; 58(12):1615-1625. PubMed ID: 34181081
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
[TBL] [Abstract][Full Text] [Related]
31. Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study.
Ramezankhani A; Azizi F; Hadaegh F
Cardiovasc Diabetol; 2022 Nov; 21(1):227. PubMed ID: 36324143
[TBL] [Abstract][Full Text] [Related]
32. Discordance of Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol Particle Versus Cholesterol Concentration for the Prediction of Cardiovascular Disease in Patients With Metabolic Syndrome and Diabetes Mellitus (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
Tehrani DM; Zhao Y; Blaha MJ; Mora S; Mackey RH; Michos ED; Budoff MJ; Cromwell W; Otvos JD; Rosenblit PD; Wong ND
Am J Cardiol; 2016 Jun; 117(12):1921-7. PubMed ID: 27156827
[TBL] [Abstract][Full Text] [Related]
33. Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Cohort Project.
Vishram JK; Borglykke A; Andreasen AH; Jeppesen J; Ibsen H; Jørgensen T; Palmieri L; Giampaoli S; Donfrancesco C; Kee F; Mancia G; Cesana G; Kuulasmaa K; Salomaa V; Sans S; Ferrieres J; Dallongeville J; Söderberg S; Arveiler D; Wagner A; Tunstall-Pedoe H; Drygas W; Olsen MH;
PLoS One; 2014; 9(9):e107294. PubMed ID: 25244618
[TBL] [Abstract][Full Text] [Related]
34. Association between systemic immune-inflammation index and metabolic syndrome and its components: results from the National Health and Nutrition Examination Survey 2011-2016.
Zhao Y; Shao W; Zhu Q; Zhang R; Sun T; Wang B; Hu X
J Transl Med; 2023 Oct; 21(1):691. PubMed ID: 37794370
[TBL] [Abstract][Full Text] [Related]
35. Cumulative remnant cholesterol burden increases the risk of cardiovascular disease among young adults.
Wang Y; Zhang Y; Wang X; Chen S; Tian X; Xu Q; Xia X; Wu S; Liu F; Wang A
Ann Epidemiol; 2024 Jun; 94():127-136. PubMed ID: 38735386
[TBL] [Abstract][Full Text] [Related]
36. Body size, insulin sensitivity, metabolic health and risk of cardiovascular disease in Chinese adults: Insights from the China Cardiometabolic Disease and Cancer Cohort (4C) study.
Hu C; Wang S; Lin H; Wan Q; Zheng R; Zhu Y; Li M; Xu Y; Xu M; Zheng J; Chen L; Zeng T; Hu R; Ye Z; Shi L; Su Q; Chen Y; Yu X; Yan L; Wang T; Zhao Z; Qin G; Chen G; Dai M; Zhang D; Tang X; Gao Z; Shen F; Gu X; Luo Z; Qin Y; Chen L; Hou X; Huo Y; Li Q; Wang G; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Deng H; Zhao J; Mu Y; Lai S; Li D; Ning G; Wang W; Hu W; Bi Y; Lu J;
Diabetes Obes Metab; 2024 Jun; 26(6):2176-2187. PubMed ID: 38419419
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of New Criteria for Metabolic Syndrome Optimized for Prediction of Cardiovascular Diseases in Japanese.
Yamazaki Y; Fujihara K; Sato T; Harada Yamada M; Yaguchi Y; Matsubayashi Y; Yamada T; Kodama S; Kato K; Shimano H; Sone H
J Atheroscler Thromb; 2024 Apr; 31(4):382-395. PubMed ID: 37981330
[TBL] [Abstract][Full Text] [Related]
38. Insulin resistance potentiates the effect of remnant cholesterol on cardiovascular mortality in individuals without diabetes.
Vargas-Vázquez A; Fermín-Martínez CA; Antonio-Villa NE; Fernández-Chirino L; Ramírez-García D; Dávila-López G; Díaz-Sánchez JP; Aguilar-Salinas CA; Seiglie JA; Bello-Chavolla OY
Atherosclerosis; 2024 Mar; ():117508. PubMed ID: 38570208
[TBL] [Abstract][Full Text] [Related]
39. Association of Age of Metabolic Syndrome Onset With Cardiovascular Diseases: The Kailuan Study.
Huang Z; Wang X; Ding X; Cai Z; Li W; Chen Z; Fang W; Cai Z; Lan Y; Chen G; Wu W; Chen Z; Wu S; Chen Y
Front Endocrinol (Lausanne); 2022; 13():857985. PubMed ID: 35370968
[TBL] [Abstract][Full Text] [Related]
40. Cumulative remnant cholesterol predicts cardiovascular outcomes in elderly patients with atherosclerotic cardiovascular disease.
Xiao Z; Lin Z; Xu L; Xu W; Huang H; Wang Y; Cao S; Xie Z; Liao W; Liao Y; Bin J; Feng W; Chen Y
Eur J Prev Cardiol; 2023 Nov; 30(17):1924-1934. PubMed ID: 37708385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
